Craniospinal irradiation for acute lymphoblastic leukemia with central nervous system disease at diagnosis: A report from the Children's Cancer Group

International Journal of Radiation Oncology Biology Physics

Volumn 36, Issue 1, 1996, Pages 19-27

  Cherlow, Joel M ^a,h   Sather, Harland ^b   Steinherz, Peter ^c   Gaynon, Paul ^d   Tubergen, David ^e   Trigg, Michael ^f   Novak, Louis ^g   Archie Bleyer, W ^e  

^a LONG BEACH MEMORIAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d University of Wisconsin Health   (United States)

^e UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^f UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^g UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^h CHILDREN S ONCOLOGY GROUP   (United States)

Author keywords

Acute lymphoblastic leukemia; Craniospinal irradiation

Indexed keywords

CARMUSTINE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DOXORUBICIN; HYDROXYUREA; MERCAPTOPURINE; METHOTREXATE; TIOGUANINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM METASTASIS; HUMAN; INTRATHECAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; SURVIVAL TIME; TREATMENT OUTCOME;

EID: 0029790221     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(96)00272-6     Document Type: Article

References (30)

1. J.R. Anderson J.F. Wilson R.D.T. Jenkin A.T. Meadows J. Kersey R.R. Chilcote P. Coccia P. Exelby J. Kushner S. Siegel G.D. Hammond Childhood non-Hodgkin's lymphoma: The results of a randomized therapeutic trial comparing a 4-drug regimen (COMP) with a 10-drug regimen (LSA2-L2) N. Engl. J. Med. 308 1983 559 565
2. R.J.A. Aur H.O. Hustu M.S. Verzosa A. Wood J.V. Simone A comparison of two methods of preventing CNS leukemia Blood 42 1973 349
3. W.A. Bleyer P.F. Coccia H.N. Sather C. Level J. Lukens D.J. Niebrugge S. Siegel P.S. Littman S.L. Leikin D.R. Miller R.L. Chard G.D. Hammound Reduction in CNS leukemia with a pharmacokinetically derived intrathecal methotrexate dosage regimen J. Clin. Oncol. 1 1983 317 325
4. N.E. Breslow Analysis of survival data under the proportional hazards model Int. Stat. Rev. 43 1975 45 48
5. J.M. Cherlow P.G. Steinherz H.N. Sather P.S. Gaynon N.J. Grossman J.H. Kersey H.S. Johnstone J.C. Breneman M.E. Trigg G.D. Hammond The role of radiation therapy in the treatment of acute lymphoblastic leukemia with lymphomatous presentation: A report from the Childrens Cancer Group Int. J. Radiat. Oncol. Biol. Phys. 27 1993 1001 1009
6. J.M. Chessells C. Bailey S.M. Richards Intensification of treatment and survival in all children with acute lymphoblastic leukaemia: Results of UK Medical Research Council trial UKALL X Lancet 345 1995 143 148
7. P.S. Gaynon W.A. Bleyer P.G. Steinherz J.Z. Finklestein P.S. Littman D.R. Miller G.H. Reaman H.N. Sather G.D. Hammond Modified BFM therapy for children with previously untreated acute lymphoblastic leukemia and unfavorable prognostic features: A report of Childrens Cancer Study Group, Study CCG-193P Am. J. Pediatr. Hematol. Oncol. 10 1988 42 50
8. P.S. Gaynon P.G. Steinherz W.A. Bleyer A.R. Ablin V.C. Albo J.Z. Finklestein N.J. Grossman L.J. Novak A.F. Pyesmany G.H. Reaman R.J. Chappell H.N. Sather G.D. Hammond Improved therapy for children with acute lymphoblastic leukemia and unfavorable presenting features: A follow-up report of the Childrens Cancer Group Study CCG-106 J. Clin. Oncol. 11 1993 2234 2242
9. G.S. Gilchrist D.G. Tubergen H.N. Sather P.F. Coccia R.T. O'Brien M.J. Waskerwitz G.D. Hammond Low numbers of CSF blasts at diagnosis do not predict for the development of CNS leukemia in children with intermediate-risk acute lymphoblastic leukemia: A Childrens Cancer Group report J. Clin. Oncol. 12 1994 2594 2600
10. G.D. Hammond H. Sather W.A. Bleyer P. Coccia Stratification by prognostic factors in the design and analysis of clinical trials for acute lymphoblastic leukemia T. Buchner G. Schellong W. Hiddemann D. Urbanitz J. Ritter Haematology and blood transfusion vol. 30 1987 Springer-Verlag Berlin 161 166
11. G. Henze H.J. Langermann J. Bramswig H. Breu H. Gadner G. Schellong K. Welte H.J. Riehm Ergebnisse der studie BFM 76 79 zur Behandlung der akuten lymphoblastichen Leukamie bei Kindern und Jugendlichen Klin. Paediatr. 193 1981 145 154
12. R.D.T. Jenkin Radiation in the treatment of meningeal leukemia Am. J. Pediatr. Hematol. Oncol. 1 1979 49 58
13. E.L. Kaplan P. Meier Nonparametric estimation from incomplete observations J. Am. Stat. Assoc. 53 1958 457 481
14. S. Lauer J. Shuster P. Kirchner G. Kiefer J. Pullen B. Camitta V. Land Prognostic significance of cerebrospinal fluid lymphoblasts at diagnosis in children with acute lymphoblastic leukemia [abstr.] Proc. Am. Soc. Clin. Oncol. 13 1994 317
15. H.H. Mahmoud G.K. Rivera M.L. Hancock R.A. Krance L.E. Kun F.G. Behm R.C. Ribeiro J.T. Sandlund W.M. Crist C.H. Pui Low leukocyte counts with blast cells in cerebrospinal fluid of children with newly diagnosed acute lymphoblastic leukemia N. Engl. J. Med. 329 1993 314 319
16. N. Mantel Evaluation of survival data and two new rank order statistics arising in its consideration Cancer Chemother. Rep. 50 1966 163 170
17. R. Mastrangelo D. Poplack A. Bleyer R. Riccardi H. Sather G. D'Angio Report and recommendations of the Rome workshop concerning poor-prognosis acute lymphoblastic leukemia in children: Biologic bases for staging, stratification, and treatment Med. Pediatr. Oncol. 14 1986 191 194
18. D.R. Miller S. Leikin V. Albo H. Sather M. Karon D. Hammond Prognostic factors and therapy in acute lymphoblastic leukemia of childhood: CCG-141. A report from Childrens Cancer Study Group Cancer 51 1983 1041 1049
19. M.E. Nesbit H. Sather L.L. Robison M. Donaldson P. Littman J.A. Ortega G.D. Hammond Sanctuary therapy: A randomized trial of 724 children with previously untreated acute lymphocytic leukemia. A report from the Childrens Cancer Study Group Cancer Res. 42 1982 674 680
20. R. Peto M.C. Pike P. Armitage N.E. Breslow D.R. Cox S.V. Howard N. Mantel K. McPherson J. Peto P.G. Smith Design and analysis of randomized clinical trials requiring prolonged observation of each patient. Part II. Analysis and examples Br. J. Cancer 35 1977 1 39
21. D.G. Poplack G.H. Reaman W.A. Bleyer J. Feusner L. Odom S. Steinberg H. Sather D. Hammond Successful prevention of central nervous system (CNS) leukemia without cranial radiation in children with high risk acute lymphoblastic leukemia (ALL): A preliminary report [abstr.] Proc. Am. Soc. Clin. Oncol. 8 1989 213
22. A. Reiter M. Schrappe W.D. Ludwig W. Hiddemann S. Sauter G. Henze M. Zimmermann F. Lampert W. Havers D. Niethammer E. Odenwald J. Ritter G. Mann K. Welte H. Gadner H. Riehm Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86 Blood 84 1994 3122 3133
23. L.L. Robison H.N. Sather P.F. Coccia M.E. Nesbit G.D. Hammond Assessment of the interrelationship of prognostic factors in childhood acute lymphoblastic leukemia: A report from the Childrens Cancer Study Group Am. J. Pediatr. Hematol. Oncol. 2 1980 5 13
24. S.M. Shalet B. Gibson R. Swindell D. Pearson Effect of spinal irradiation on growth Arch. Dis. Child. 62 1987 461 464
25. P.G. Steinherz P. Gaynon D.R. Miller G. Reaman A. Blever J. Finklestein R.G. Evans P. Meyers L.J. Steinherz H. Sather D. Hammond Improved disease-free survival of children with acute lymphoblastic leukemia at high risk for early relapse with the New York regimen: A new intensive therapy protocol. A report from the Childrens Cancer Study Group J. Clin. Oncol. 4 1986 744 752
26. P.G. Steinherz S.E. Siegel W.A. Bleyer R. Kersey R. Chard P. Coccia S. Leikin S. Lukens R. Neerhout M. Nesbit D.R. Miller G. Reaman H. Sather D. Hammond Lymphomatous presentation of childhood acute lymphoblastic leukemia: A subgroup at high risk of early treatment failure Cancer 68 1991 751 758
27. D.G. Tubergen G.S. Gilchrist R.T. O'Brien P.F. Coccia H.N. Sather M.J. Waskerwitz G.D. Hammond Prevention of CNS disease in intermediate-risk acute lymphoblastic leukemia: Comparison of cranial radiation and intrathecal methotrexate and the importance of systemic therapy: A Childrens Cancer Group Report J. Clin. Oncol. 11 1993 520 526
28. D.G. Tubergen G.S. Gilchrist R.T. O'Brien P.F. Coccia H.N. Sather M.J. Waskerwitz G.D. Hammond Improved outcome with delayed intensification for children with acute lymphoblastic leukemia and intermediate presenting features: A Childrens Cancer Group phase III Trial J. Clin. Oncol. 11 1993 527 537
29. M.L.N. Willoughby Treatment of overt meningeal leukemia in children: Results of second MRC meningeal leukemia trial BMJ i 1976 864 867
30. N. Wollner J.H. Burchenal P.H. Liebermann NonHodgkins lymphoma in children: A comparative study of two modalities of therapy Cancer 37 1976 123 134